Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.
Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim...
https://pubmed.ncbi.nlm.nih.gov/37449887/Actively Recruiting
Led by Myositis International Health & Research Collaborative Alliance Foundation · Updated on 2026-01-28
700
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting a global observational study to understand the research priorities of people living with rare myositis diseases. These conditions present physical and psychosocial challenges that current research may not fully address. The study gathers patient perspectives to identify the most important research questions from their viewpoint, aiming to guide future research and funding decisions. This largely online study uses qualitative and mixed methods such as open-ended questions, interactive focus groups, community forums, and surveys to collect insights from adults and children diagnosed with inflammatory myopathies, as well as optionally their caregivers or partners. Participants share their priorities and experiences related to myositis diseases to help shape the research agenda. Participants engage by providing narratives, participating in forums, and completing surveys that last up to 90 minutes. Researchers analyze these contributions to create a structured set of patient-voiced research priorities. The study monitors these priorities as the primary outcome measure and aims to develop a framework to guide future consensus and research planning. Participation involves mostly online activities, making it accessible and convenient for those involved.
CONDITIONS
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
L
Lesley Ann Saketkoo, MD/MPH
B
Barbara Shafranski
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Myositis International Health & Research Collaborative Alliance Foundation
Lead Sponsor
MIHRA Patient Advisory
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (online or in-person)
Duration - Up to 90 minutes per activity
Participants share their experiences and research priorities through open-ended narratives, interactive focus groups, and forums.
1 to multiple online sessions depending on participation
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim...
https://pubmed.ncbi.nlm.nih.gov/37449887/Aviya Lanis, Helene Alexanderson, Kaveh Ardalan...
https://pubmed.ncbi.nlm.nih.gov/38488093/Lesley Ann Saketkoo, Julie J Paik, Helene Alexanderson...
https://pubmed.ncbi.nlm.nih.gov/38436382/Myositis International Health & Research Collaborative Alliance Foundation
Lead Sponsor
MIHRA Patient Advisory
Collaborating Sponsor